Clinical Trials Browser

Anal Canal Carcinoma, Anus Neoplasms

Carcinoma, Renal Cell, Lymphatic Metastasis

Oropharyngeal Neoplasms

Carcinoma, Renal Cell

Urothelial Cancer

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Carcinoma, Hepatocellular

Urinary Bladder Neoplasms

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Stomach Neoplasms

Hodgkin Disease

Carcinoma, Hepatocellular, Liver Neoplasms

Various Advanced Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Colorectal Neoplasms

Brain Neoplasms, Melanoma

Carcinoma, Carcinoma, Renal Cell, Neoplasms

Carcinoma, Renal Cell, Disease Progression

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Carcinoma, Ovarian Epithelial, Pathologic Complete Response, Fallopian Tube Neoplasms, Neoplasms

Carcinoma, Renal Cell

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Carcinoma, Transitional Cell

Stomach Neoplasms

Clinical Trials

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

CheckMate901

STAR-221

CheckMate 9DW

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

FORTITUDE-102

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

CheckMate 9DX

CheckMate 274

Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

CheckMate-67T

CheckMate 8HW

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

COSMIC-313

CheckMate76K

RELATIVITY-127

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

INTEGRATEIIb

UNIVERSE

ATHENA

CheckMate 9ER

NIVOPOSTOP

NADIM-ADJUVANT

IMAGINE

A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NADINA